Interest of new alkylsulfonylhydrazide-type compound in the treatment of alcohol use disorders.

Our study demonstrated that a new compound designed to target HDAC-1 is effective in reducing ethanol intake and relapse in rats and further confirm the interest of pursuing research to study the exact mechanism by which such inhibitor may be useful to treat AUDs.